Organization | University of Regina

University of Regina Report issue

Academic/Hospital Phase 2 Phase 3

Founded: Regina Canada (1974)

Organization Overview

First Clinical Trial

2013

NCT01846117

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Assoicate Dean of Kinesiology | University of Regina

Active Ingredients

Drugs in Phase 3 Trials (5)

dexmedetomidine (precedex) (1 trial)

fentanyl (Innovar) (1 trial)

levobupivacaine (chirocaine) (1 trial)

midazolam (versed) (1 trial)

sodium chloride (1 trial)

Drugs in Phase 2 Trials (5)

creatine (5 trials)

maltodextrin (3 trials)

secoisolariciresinol diglucoside (1 trial)

vitamin d3 (1 trial)

whey protein (2 trials)

Drugs in Other Trials (2)

caffeine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Inflammation (Phase 2)

Pain, Postoperative (Phase 3)

Sarcopenia (Phase 2)

Overview

Highest Phase: Phase 3
# of Trials: 8
# of Trial APIs: 12